These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4792935)

  • 1. Effect of administration of clofibrate and clofenapate on the activities of glycerolphosphate dehydrogenase and catalase in rat kidney mitochondria.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1973 Sep; 10(3):224-7. PubMed ID: 4792935
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of administration of clofibrate and clofenapate on the content and distribution of ubiquinone in rat tissues.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1974 Mar; 11(1):51-3. PubMed ID: 4435808
    [No Abstract]   [Full Text] [Related]  

  • 3. A kinetic comparison of the physiological effects of clofibrate and clofenapate in the rat.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(2):80-8. PubMed ID: 4459126
    [No Abstract]   [Full Text] [Related]  

  • 4. Interlobular differences in the changes induced in rat liver by clofibrate and clofenapate.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(5):243-50. PubMed ID: 4461276
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of administration of clofibrate and clofenapate on kidney mitochondria of the rat.
    Krishnakantha TP; Kurup CK
    Biochem Pharmacol; 1973 May; 22(10):1245-7. PubMed ID: 4707606
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase in hepatic catalase and glycerol phosphate dehydrogenase activities on administration of clofibrate and clofenapate to the rat.
    Krishnakantha TP; Kurup CK
    Biochem J; 1972 Nov; 130(1):167-75. PubMed ID: 4655418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK
    Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clofibrate on Tetrahymena.
    Blum JJ; Wexler JP
    Mol Pharmacol; 1968 Mar; 4(2):155-61. PubMed ID: 5645611
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of administration of clofibrate and clofenapate on oxidative phosphorylation by liver mitochondria in the rat.
    Krishnakantha TP; Mohan VP; Chhabra S; Kurup CK
    Indian J Biochem Biophys; 1975 Mar; 12(1):31-4. PubMed ID: 1205484
    [No Abstract]   [Full Text] [Related]  

  • 11. Decrease in aldolase activity in the livers of clofenapate-treated rats.
    Ramasarma T; Ting SM; Horecker BL
    Indian J Biochem; 1971 Jun; 8(2):87-9. PubMed ID: 4259437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
    Araki Y; Amagase H
    Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120
    [No Abstract]   [Full Text] [Related]  

  • 13. The tritium isotope effect of sn-glycerol 3-phosphate oxidase and the effects of clofenapate and N-(2-benzoyloxyethyl)norfenfluramine on the esterification of glycerol phosphate and dihydroxyacetone phosphate by rat liver mitochondria.
    Bowley M; Manning R; Brindlay DN
    Biochem J; 1973 Oct; 136(2):421-7. PubMed ID: 4149445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced and naturally occurring myeloid bodies.
    Hruban Z; Slesers A; Hopkins E
    Lab Invest; 1972 Jul; 27(1):62-70. PubMed ID: 4402449
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth and liver glycerophosphate dehydrogenase response to thyroxine and p-chlorophenoxyisobutyrate.
    Richert DA; Westerfeld WW
    Endocrinology; 1970 Dec; 87(6):1274-81. PubMed ID: 5529883
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of aldehyde dehydrogenase activity in rat liver by clofibrate feeding.
    Kramar R; Kremser K
    Enzyme; 1984; 31(1):17-20. PubMed ID: 6714196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation kinetics of liver catalase in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate.
    Chiga M; Reddy J; Svoboda D
    Lab Invest; 1971 Jul; 25(1):49-52. PubMed ID: 5555696
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacologic study of a hypocholesteremic agent (MG. 46)].
    Nordmann J; Loiseau G; Berthe G; Lohier P; Truchaud M
    Therapie; 1972; 27(2):339-58. PubMed ID: 4673514
    [No Abstract]   [Full Text] [Related]  

  • 19. The hypocholesterolemic action of eritadenine in the rat.
    Takashima K; Izumi K; Iwai H; Takeyama S
    Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ; Azarnoff DL
    Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.